Found: 31
Select item for more details and to access through your institution.
The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3–TCR molecules after their engagement by mAb or peptide–MHC class I complexes.
- Published in:
- International Immunology, 1999, v. 11, n. 11, p. 1745, doi. 10.1093/intimm/11.11.1745
- By:
- Publication type:
- Article
Analysis of T-cell immune response in renal cell carcinoma: Polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 3, p. 431, doi. 10.1002/(SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.0.CO;2-F
- By:
- Publication type:
- Article
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 6, p. 972, doi. 10.1002/(SICI)1097-0215(19970611)71:6<972::AID-IJC11>3.0.CO;2-8
- By:
- Publication type:
- Article
In situ demonstration of renal-cell-carcinoma-specific T-cell clones.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 4, p. 564, doi. 10.1002/(SICI)1097-0215(19960516)66:4<564::AID-IJC23>3.0.CO;2-6
- By:
- Publication type:
- Article
Low-dose IL-2 treatment: Activation of discrete T- and NK-cell sub-populations in vivo.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 5, p. 523, doi. 10.1002/ijc.2910620506
- By:
- Publication type:
- Article
The decreased expression of CD3 ζ chains in cancer patients is not reversed BY IL-2 Administration.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 6, p. 752, doi. 10.1002/ijc.2910590607
- By:
- Publication type:
- Article
Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon γ: Immunological monitoring.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 6, p. 814, doi. 10.1002/ijc.2910570609
- By:
- Publication type:
- Article
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma.
- Published in:
- International Journal of Cancer, 1993, v. 54, n. 5, p. 741, doi. 10.1002/ijc.2910540506
- By:
- Publication type:
- Article
Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patients.
- Published in:
- International Journal of Cancer, 1993, v. 54, n. 1, p. 60, doi. 10.1002/ijc.2910540111
- By:
- Publication type:
- Article
Media conditioned by human leukemic T-cells induce expression of IL2 receptors and proliferation of normal T lymphocytes.
- Published in:
- International Journal of Cancer, 1986, v. 37, n. 2, p. 247, doi. 10.1002/ijc.2910370213
- By:
- Publication type:
- Article
LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors.
- Published in:
- Immunology, 2005, v. 114, n. 3, p. 369, doi. 10.1111/j.1365-2567.2004.02087.x
- By:
- Publication type:
- Article
Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 7, p. 1893, doi. 10.1038/jid.2014.29
- By:
- Publication type:
- Article
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-97
- By:
- Publication type:
- Article
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 71, doi. 10.1186/1479-5876-8-71
- By:
- Publication type:
- Article
Antigen-specific proliferative human T cell clones with specificity for diphtheria toxoid: genetic and molecular restriction by class II antigens.
- Published in:
- European Journal of Immunology, 1984, v. 14, n. 8, p. 697, doi. 10.1002/eji.1830140805
- By:
- Publication type:
- Article
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 10, p. 2885, doi. 10.1002/1521-4141(2001010)31:10<2885::AID-IMMU2885>3.0.CO;2-2
- By:
- Publication type:
- Article
KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 6, p. 1728, doi. 10.1002/1521-4141(200106)31:6<1728::AID-IMMU1728>3.0.CO;2-J
- By:
- Publication type:
- Article
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses.
- Published in:
- European Journal of Immunology, 1999, v. 29, n. 12, p. 3867, doi. 10.1002/(SICI)1521-4141(199912)29:12<3867::AID-IMMU3867>3.0.CO;2-E
- By:
- Publication type:
- Article
T cell major histocompatibility complex class II molecules down-regulate CD4.
- Published in:
- European Journal of Immunology, 1996, v. 26, n. 5, p. 1180, doi. 10.1002/eji.1830260533
- By:
- Publication type:
- Article
CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
- Published in:
- European Journal of Immunology, 1995, v. 25, n. 9, p. 2718, doi. 10.1002/eji.1830250949
- By:
- Publication type:
- Article
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4.
- Published in:
- European Journal of Immunology, 1994, v. 24, n. 12, p. 3216, doi. 10.1002/eji.1830241246
- By:
- Publication type:
- Article
Molecular characterization of human T cell receptor α chains including a V.
- Published in:
- European Journal of Immunology, 1991, v. 21, n. 4, p. 1061, doi. 10.1002/eji.1830210430
- By:
- Publication type:
- Article
Studies on the human T cell receptor α/β variable region genes. II. Identification of four additional V.
- Published in:
- European Journal of Immunology, 1991, v. 21, n. 4, p. 935, doi. 10.1002/eji.1830210412
- By:
- Publication type:
- Article
Studies on the human T cell receptor α/β variable region genes. I. Identification of 7 additional V.
- Published in:
- European Journal of Immunology, 1991, v. 21, n. 4, p. 927, doi. 10.1002/eji.1830210411
- By:
- Publication type:
- Article
cDNA cloning of functional T cell receptor γ/δ chains expressed in human peripheral blood lymphocytes.
- Published in:
- European Journal of Immunology, 1989, v. 19, n. 9, p. 1545, doi. 10.1002/eji.1830190905
- By:
- Publication type:
- Article
A novel human V.
- Published in:
- European Journal of Immunology, 1988, v. 18, n. 12, p. 2021, doi. 10.1002/eji.1830181223
- By:
- Publication type:
- Article
Cloned CD3.
- Published in:
- European Journal of Immunology, 1988, v. 18, n. 11, p. 1671, doi. 10.1002/eji.1830181104
- By:
- Publication type:
- Article
Further evidence for a sequentially ordered activation of T cell rearranging gamma genes during T lymphocyte differentiation.
- Published in:
- European Journal of Immunology, 1988, v. 18, n. 5, p. 789, doi. 10.1002/eji.1830180520
- By:
- Publication type:
- Article
Cloned human CD3.
- Published in:
- European Journal of Immunology, 1987, v. 17, n. 8, p. 1209, doi. 10.1002/eji.1830170819
- By:
- Publication type:
- Article
Immune response to diphtheria toxin and to different CNBr fragments: Evidence for different B and T cell reactivities.
- Published in:
- European Journal of Immunology, 1986, v. 16, n. 1, p. 47, doi. 10.1002/eji.1830160110
- By:
- Publication type:
- Article